Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Privia Health Group Inc shares valued at $2,500,127 were sold by Mehrotra Parth on Sep 10 ’24. At $18.50 per share, Mehrotra Parth sold 135,142 shares. The insider’s holdings dropped to 247,771 shares worth approximately $5.34 million following the completion of this transaction.
Also, Mehrotra Parth purchased 135,142 shares, netting a total of over 2,500,719 in proceeds.
Before that, Boehler Adam had added 364 shares to its account. In a trade valued at $6,006, the Director bought Privia Health Group Inc shares for $16.50 each. Upon closing the transaction, the insider’s holdings increased to 364 shares, worth approximately $124.53 million.
As published in their initiating research note from Needham on January 10, 2025, Privia Health Group Inc [PRVA] has been a Buy and the price target has been revised to $25. Analysts at Macquarie started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of October 11, 2024, KeyBanc Capital Markets has initiated its “an Overweight” rating for PRVA. Earlier on May 30, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PRVA stock.
Analyzing PRVA Stock Performance
During the last five days, there has been a surge of approximately 6.26%. Over the course of the year, Privia Health Group Inc shares have jumped approximately 10.33%. Shares of the company reached a 52-week high of $21.67 on 01/15/25 and a 52-week low of $19.47 on 01/02/25. A 50-day SMA is recorded $20.93, while a 200-day SMA reached $18.95. Nevertheless, trading volume fell to 0.61 million shares from 0.36 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 21.07, which, if violated, would cause prices to drop to 20.57. In the upper region, resistance lies at 21.87. The next price resistance is at 22.17. RSI (Relative Strength Index) is 61.20 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.83, which suggests the price will decrease in the coming days. Percent R is at 3.98%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.